Ketamine Korner: Edition 12
Ketamine Korner is a bi-weekly newsletter exploring advances in ketamine therapy, originally started by Mind Pain Relief Institute Co-Founder Dr. Rohit Aiyer.
Each edition is republished with permission from Dr. Aiyer.
Latest Research Highlight:
Research Update: Anhedonia is one of the most disabling symptoms of depression and is often resistant to traditional antidepressants.
A study published in JAMA Psychiatry (Ballard et al., 2018) found that ketamine produced rapid reductions in anhedonia, measurable within hours of infusion. Importantly, these improvements were partially independent of overall changes in depressive symptoms, suggesting a distinct mechanism.
Additional work from the same group demonstrated that ketamine’s effects on reward processing may be mediated through dopaminergic and glutamatergic pathways, particularly in brain regions such as the ventral striatum, central to motivation and reward (Ballard & Zarate, 2020).
These findings suggest ketamine may target core motivational circuitry, rather than only improving mood broadly.
A Brief History of Anhedonia in Depression Research:
Beyond “Low Mood”:
Historically, depression was conceptualized primarily as sadness or low mood. Over time, researchers recognized that loss of pleasure and motivation can be equally, if not more, impairing.
Limitations of Traditional Treatments: Many conventional antidepressants improve mood but have limited impact on anhedonia, which is linked to poorer functional outcomes.
Ketamine’s Rapid Effects: Ketamine’s fast-acting profile led researchers to examine whether it could influence reward processing directly, rather than through gradual mood changes.
Current Perspective: Anhedonia is now considered a distinct therapeutic target, and ketamine is one of the few interventions showing rapid, measurable effects in this domain.
Mythbuster:
Myth: Ketamine only improves mood and does not address deeper symptoms like lack of motivation or pleasure.
Reality:
Studies show ketamine can rapidly reduce anhedonia, sometimes before overall mood improves.
These effects may reflect direct changes in reward circuitry, not just general antidepressant action.
Functional improvements (motivation, engagement) may follow when these systems are activated.
Ketamine is not a complete solution—but it may help restore the capacity to feel and engage, which is often central to recovery.
Key Takeaway:
Ketamine’s effects may extend beyond mood improvement to core motivational systems. By targeting neural circuits involved in reward and engagement, it may help address symptoms that are often resistant to standard treatments.
As research evolves, focusing on specific symptom domains, not just overall depression scores, may lead to more precise and effective care.
Until next time, stay curious and engaged with the possibilities ahead.